Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational StudyObservational Study Published on 2023-04-092023-06-01 Journal: International Journal of Molecular Sciences [Category] 두창, 수두, 홍역, [키워드] Biological agents herpes zoster Personalized medicine rheumatoid arthritis vaccine. [DOI] 10.3390/ijms24086967 PMC 바로가기 [Article Type] Observational Study
Conventional, biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors and varicella zoster virusReview Published on 2023-04-012023-05-31 Journal: Expert opinion on pharmacotherapy [Category] 두창, 수두, 홍역, [키워드] bDMARDs cDMARDs herpes zoster HZ jak inhibitors rheumatoid arthritis Spondyloarthritis. [DOI] 10.1080/14656566.2023.2195050 PMC 바로가기 [Article Type] Review
Herpes zoster in patients with inflammatory arthritides or ulcerative colitis treated with tofacitinib, baricitinib or upadacitinib: a systematic review of clinical trials and real-world studiesArticle Published on 2023-03-012023-06-01 Journal: Rheumatology International [Category] 두창, 수두, 홍역, [키워드] herpes zoster jak inhibitors rheumatoid arthritis spondyloarthritis systematic review ulcerative colitis. [DOI] 10.1007/s00296-022-05270-6 PMC 바로가기
Opportunistic infections associated with Janus kinase inhibitor treatment for rheumatoid arthritis: A structured literature reviewReview Published on 2023-02-012023-06-01 Journal: Seminars in arthritis and rheumatism [Category] 두창, 수두, 홍역, [키워드] herpes zoster JAK inhibitor opportunistic infection Pneumocystis carinii pneumonia rheumatoid arthritis tuberculosis. [DOI] 10.1016/j.semarthrit.2022.152120 PMC 바로가기 [Article Type] Review
Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based VaccinesArticle Published on 2022-12-012023-07-10 Journal: The Journal of rheumatology [Category] COVID19(2023년), [키워드] Argentina COVID-19 rheumatoid arthritis SARS-CoV-2 Vaccines. [DOI] 10.3899/jrheum.220469 PMC 바로가기
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal studyMulticenter Study Published on 2022-12-012023-07-10 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), [키워드] Antibody Response COVID-19 vaccine immunosuppressive therapy rheumatoid arthritis SARS-CoV-2 T-cell response. [DOI] 10.1016/j.ijid.2022.10.035 PMC 바로가기 [Article Type] Multicenter Study
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patientsArticle Published on 2022-12-012022-11-15 Journal: Annals of Medicine [Category] COVID19(2023년), SARS, 진단, 치료제, [키워드] addition affecting alleviate antiviral medication antiviral medicine approved Baricitinib Care caused Clinical practice clinical recommendations Community courses COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 treatment COVID-19 treatments Critical deaths develop disease disorder drug Dyspnea effective effective drugs European European Medicines Agency European Union Evidence guidelines. Health healthcare hospital Hospitalization Hospitalized hospitalized patient hypoxia Intervention involved life-threatening lung involvement management Mild moderate molnupiravir monoclonal antibodies monoclonal antibody Most patient Multiorgan dysfunction New outcome public health recommendation Remdesivir Respiratory failure rheumatoid arthritis SARS-CoV-2 Septic shock severe symptom Symptom the disease the patient therapy Thromboembolism Tocilizumab treat Treatment treatment strategy union vaccination [DOI] 10.1080/07853890.2022.2133162 PMC 바로가기
Environmental pathways affecting gene expression (E.PAGE) as an R package to predict gene-environment associationsArticle Published on 2022-11-042022-11-16 Journal: Scientific Reports [Category] 유전자 메커니즘, [키워드] Abstract affecting articles association biological processe Cell comprehensive resource COVID-19 criteria curated database dataset develop diabetes differentially expressed gene dysregulated enriched biological processes environmental factor environmental factors Gene Expression Gene Expression Omnibus Genes Infection initial Interaction lung cancer pathway predict R package retrieved rheumatoid arthritis selected signature smoking statistical analysis statistically tested [DOI] 10.1038/s41598-022-21988-6 PMC 바로가기
A Mendelian randomization study of genetic predisposition to autoimmune diseases and COVID-19Article Published on 2022-10-212022-11-16 Journal: Scientific Reports [Category] 변종, [키워드] Analysis Antigen association Autoimmune disease Autoimmune diseases biliary cirrhosis concern coronavirus disease COVID-19 COVID-19 susceptibility Diabetes Mellitus disease examined Genetic predisposition Genetic variant Genome-wide association studies Genome-wide association study hospitalized COVID-19 immune response Infection juvenile idiopathic arthritis leukocyte mendelian randomization Mendelian randomization analysis multiple sclerosis performed rheumatoid arthritis severe COVID-19 severity severity of COVID-19 similarities susceptibility systemic lupus erythematosus with COVID-19 [DOI] 10.1038/s41598-022-22711-1 PMC 바로가기
Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritisArticle Published on 2022-10-122022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, 치료기술, 치료제, [키워드] addition age anti-CD20 therapy anti-S anti-S antibody anti-SARS-CoV-2 antibodies antibody Antibody Response BNT162b2 cell-mediated response Cellular immune response cellular immune responses ChAdOx1 Concentration Corona covariate adjustment COVID-19 COVID-19 vaccine declined dependent on DMARD (disease-modifying antirheumatic drug treatment) domains dose enrolled Factor healthy controls humoral IL-6 inhibitor immune response Infection inhibited investigated IQR magnitude median time mRNA-1273 Patient patients patients treated peptides positive patient reduced respiratory rheumatoid arthritis RNA RNA vaccine SARS-CoV-2 significant effect significantly Specific specific antibodies specific antibody subject T-cell T-cell Response targeted therapy the healthy the interferon the SARS-CoV-2 the vaccine therapy vaccination vaccination. Vaccine variables was measured were infected [DOI] 10.3389/fimmu.2022.960001 PMC 바로가기